A 2023 inventory in oncology news

被引：1
|
作者：
Bay, Jacques-Olivier [1 ]
Auberger, Benjamin [2 ]
Bouleuc, Carole [3 ,4 ]
Cohen, Romain [5 ,6 ]
Delom, Frederic [7 ]
Firmin, Nelly [8 ,9 ]
Gandemer, Virginie [10 ]
L'Allemain, Gilles [11 ]
Magne, Nicolas [12 ]
De Nonneville, Alexandre [13 ]
De Nonneville, Alexandre [13 ]
Orbach, Daniel [14 ]
Pellier, Isabelle [15 ]
Rodrigues, Manuel [16 ]
Wislez, Marie [17 ]
机构：
[1] CHU Clermont Ferrand, Serv Therapie Cellulaire & Hematol Clin Adulte, CHELTER UE7453, INSERM,CIC 501, Site Estaing, F-63000 Clermont Ferrand, France
[2] CHU Brest, Serv Oncol Med, ICH Morvan, F-29200 Brest, France
[3] Sorbonne Univ, Dept Soins Support, 26 Rue Ulm, F-75005 Paris, France
[4] Sorbonne Univ, Inst Curie, 26 Rue Ulm, F-75005 Paris, France
[5] Sorbonne Univ, Equipe Labellisee Ligue Natl Canc, Equipe Instabilite Microsatellites & Canc, Serv Oncol Med,Hop St Antoine,AP HP,INSERM,UMRS 9, F-75012 Paris, France
[6] Sorbonne Univ, SIRIC CURAMUS, Ctr Rech St Antoine, F-75012 Paris, France
[7] Univ Bordeaux, ARTiSt Lab, INSERM, U1312, F-33000 Bordeaux, France
[8] ICM Montpellier, 208 Ave Apothicaires, F-34298 Montpellier, France
[9] Univ Montpellier, INSERM, U1194, IRCM, 208 Ave Apothicaires, F-34298 Montpellier, France
[10] CHU Rennes, Serv Hematooncol Pediat, F-35000 Rennes, France
[11] Univ Cote Azur, CNRS, Inst Biol Valrose, INSERM, F-06108 Nice, France
[12] Inst Bergonie, Dept Radiotherapie, Bordeaux, France
[13] Inst Paoli Calmettes, Dept Oncol Med, Marseille, France
[14] PSL Univ, Inst Curie, Ctr Integre Soins & Rech Oncol Enfant Adolescent, 26 Rue Ulm, F-75005 Paris, France
[15] CHU Angers, Unite Oncohematol Pediat, F-49000 Angers, France
[16] PSL Res Univ, Inst Curie, Dept Oncol Med, 26 Rue Ulm, F-75005 Paris, France
[17] Hop Cochin, AP HP Ctr, Unite Oncol Thorac, Serv Pneumol, F-75000 Paris, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 01期
关键词：
New treatments in; oncology; Updates in 2023; OPEN-LABEL; PLUS CHEMOTHERAPY; HODGKIN LYMPHOMA; PHASE-III; CANCER; PEMBROLIZUMAB; CARCINOMA; NIVOLUMAB; STAGE; MULTICENTER;
D O I：
10.1016/j.bulcan.2023.12.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In 2023, the improvement of our therapeutic management has largely taken shape. The aim of our article is to highlight the major advances that will change our practices. These are not only in the field of treatment, but also in the improvement of supportive care. Here, we present these new developments organ by organ, cancer by cancer. You can read everything or concentrate on the cancers that are your areas of expertise. But this exhaustiveness should be representative of our current state of progress.
引用
收藏
页码：18 / 32
页数：15
相关论文
共 50 条
12345